|
⚲
|
| Vitae Pharmaceuticals Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001157602 |
| Sale | 2009-06-05 ($15.0 M Offered, $15.0 M Sold) |
| Fund | |
| Phone | 2154612000 |
| Address | 502 West Office Center Dr Fort Washington, 19034 |
| Source | [EDGAR] |
| Fund AUM and Sold ($M) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2025 |
|---|---|
| Charles Newhall | |
| Robert Gunderson | |
| James Tananbaum | |
| Tina Fiumenero | |
| Richard Gregg | |
| Peter Barrett | |
| Donald Hayden | |
| Bryan Roberts | |
| Jeffrey Hatfield |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
Flagship Capital Partners Equity Opportunity Fund II LP
✚
|
0.0 | |
|
Flame Biosciences, Inc.
✚
|
0.0 | |
|
Ellavoz Neighborhood Homes Fund, LLC
✚
|
0.0 | |
|
Polovin Andrew
✚
|
0.0 | |
|
Flexio Holdings Ltd
✚
|
0.0 | |
|
Flexion Therapeutics Inc
✚
|
0.0 | |
|
FIMI 7 2020 Ltd
✚
|
0.0 | |
|
Pope Stephanie F
✚
|
0.0 | |
|
Flores James A.
✚
|
0.0 | |
|
Clearlyrated, Inc.
✚
|
0.0 |